Sphera Funds Management’s Precision BioSciences DTIL Stock Holding History

Sphera Funds Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,000	Closed	-$220K	–	113
2026 Q1	$220K	Sell	40,000 -356,116	-90%	-$1.64M	0.03%	94
2025 Q4	$1.65M	Buy	+396,116	New	+$2.25M	0.32%	79
2020 Q2	–	Sell	-4,912	Closed	-$889K	–	97
2020 Q1	$889K	Sell	4,912 -11,546	-70%	-$3.02M	0.11%	64
2019 Q4	$6.86M	Buy	16,458 +4,291	+35%	+$1.35M	0.57%	39
2019 Q3	$3.06M	Buy	12,167 +1,000	+9%	+$325K	0.47%	58
2019 Q2	$4.44M	Buy	11,167 +3,667	+49%	+$1.48M	0.61%	50
2019 Q1	$4.04M	Buy	+7,500	New	+$3.98M	0.37%	65

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sphera Funds Management's DTIL Position: Q2 2026 in Review

Sphera Funds Management sold out of Precision BioSciences (DTIL) in Q2 2026, closing a stake of 40,000 shares — an estimated $220K sold.

Sphera Funds Management first reported a position in DTIL in Q1 2019 and held it in 7 quarters. The position peaked at $6.86M in Q4 2019. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Sphera Funds Management reported no remaining Precision BioSciences position as of Q2 2026 after selling out during the quarter.
Sphera Funds Management sold 40,000 Precision BioSciences shares in Q2 2026, an estimated $220K.
Sphera Funds Management first reported a position in Precision BioSciences in Q1 2019 and held it in 7 quarters.
Sphera Funds Management's Precision BioSciences position peaked at $6.86M in Q4 2019.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.